Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Pfizers revenue from Xtandi reached approximately $565 million in the fourth quarter, reflecting a 24% year-over-year increase and totaled $2.04 billion for the year, accounting for approximately 3% of the companys total revenue, reflecting a significant increase from the previous years revenue of $1.66 billion
In autoimmune disease , after HUMIRAs patent expiration, Sanofi and Regenerons IL-4R antibody Dupixent became the top seller, with 3.48 billion in Q1 sales, a 20.3% YoY increase
Comprehensive Support Beyond the Prescription Semaglutide works best when combined with lifestyle changes
Real Success Stories Don't just take our word for it
US$ 29.67
US$ 26.07
US$ 28.79
US$ 24.00
US$ 29.56
